Mariska van Dijk RN MSc (1966) is a nurse and lecturer nursing at the university of applied sciences in Utrecht. She studied Nursing Science at University Medical Centre in Utrecht. For her master thesis she studied the availability of instruments to screen for depressive symptoms in patients after stroke with aphasia and the psychometric properties of a non-language based depression screening instrument.
- May 2015- now: Lecturer Bachelor of Nursing University of Applied Sciences Utrecht, Faculty of Health Care;
- June 2011 - now: PhD Candidate University of Applied Sciences Utrecht, Faculty of Health Care, Research Centre for Innovation in Health Care, Research group chronical illnesses on the study 'Detection of Depression in the Early Stage of Stroke: new opportunities in nursing care;
- 2009 - 2011: Project Assistant Rehabilitation Management Team, Sint Maartenskliniek Nijmegen, Department of rehabilitation;
- 2008 - 2010: Utrecht University, Nursing Science, Research on the psychometric properties of a non-language based depression screening instrument for patients with aphasia after a stroke;
- 1996 - 2009: RN Nurse and team coach Sint Maartens Nijmegen, Department of Clinical;
- 1988 - 1996: RN Nurse and nursing team leader psychiatric hospital ‘Gelderse Roos’ Wolfheze;
- Member Association of Nurses Netherlands (V&VN), Neuro department and Rehabilitation;
- Member of working group ‘Stroke’ V&VN Department of Neuro and Rehabilitation;
- Member Rho Chi Chapter Sigma Theta Tau International Mariska is a member of the research Group for Chronical Illnesses. Her research will focus on the early detection of depression in patients after stroke with communicative impairments.
As part of her PhD program Mariska is developing a toolkit for nurses, the Post Stroke Depression Toolkit. This PSD-toolkit facilitates nurses to identify depressive symptoms in patients post-stroke and early intervention efforts. Mariska also focuses on the (further) development and validation of a measuring instrument which is suitable for screening for depressive symptoms in patients with communicative impairments after a stroke.